Personal information

No personal information available

Activities

Employment (1)

Moffitt Cancer Center: Tampa, FL, US

Employment
Source: Self-asserted source
Hatem Soliman

Works (12)

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial

Nature Medicine
2025-01-17 | Journal article
Contributors: Alicia F. C. Okines; Giuseppe Curigliano; Nobumasa Mizuno; Do-Youn Oh; Andree Rorive; Hatem Soliman; Shunji Takahashi; Tanios Bekaii-Saab; Mark E. Burkard; Ki Y. Chung et al.
Source: check_circle
Crossref

Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

Nature Medicine
2023-12 | Journal article
Contributors: Hatem Soliman; Deanna Hogue; Hyo Han; Blaise Mooney; Ricardo Costa; Marie C. Lee; Bethany Niell; Angela Williams; Alec Chau; Shannon Falcon et al.
Source: check_circle
Crossref

Data from Clinical Significance of <i>PIK3CA</i> and <i>ESR1</i> Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

2023-03-31 | Preprint
Contributors: Sara M. Tolaney; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Antonio Llombart-Cussac; Hatem Soliman; Hong Wang; Sameera Wijayawardana; Valerie M. Jansen et al.
Source: check_circle
Crossref

Data from Clinical Significance of <i>PIK3CA</i> and <i>ESR1</i> Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

2023-03-31 | Preprint
Contributors: Sara M. Tolaney; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Antonio Llombart-Cussac; Hatem Soliman; Hong Wang; Sameera Wijayawardana; Valerie M. Jansen et al.
Source: check_circle
Crossref

Supplementary Data from Clinical Significance of <i>PIK3CA</i> and <i>ESR1</i> Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

2023-03-31 | Preprint
Contributors: Sara M. Tolaney; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Antonio Llombart-Cussac; Hatem Soliman; Hong Wang; Sameera Wijayawardana; Valerie M. Jansen et al.
Source: check_circle
Crossref

Supplementary Data from Clinical Significance of <i>PIK3CA</i> and <i>ESR1</i> Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

2023-03-31 | Preprint
Contributors: Sara M. Tolaney; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Antonio Llombart-Cussac; Hatem Soliman; Hong Wang; Sameera Wijayawardana; Valerie M. Jansen et al.
Source: check_circle
Crossref

Behavioral beliefs about genetic counseling among high‐risk Latina breast cancer survivors in Florida and Puerto Rico

Cancer Medicine
2023-02 | Journal article
Contributors: Jessica N. Rivera Rivera; Claire C. Conley; Eida M. Castro‐Figueroa; Laura Moreno; Julie Dutil; Jennifer D. García; Charité Ricker; Gwendolyn P. Quinn; Hatem Soliman; Susan T. Vadaparampil
Source: check_circle
Crossref

Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

Nature Medicine
2023-02 | Journal article
Contributors: Hatem Soliman; Deanna Hogue; Hyo Han; Blaise Mooney; Ricardo Costa; Marie C. Lee; Bethany Niell; Angela Williams; Alec Chau; Shannon Falcon et al.
Source: check_circle
Crossref

Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

Clinical Cancer Research
2022-04-14 | Journal article
Contributors: Sara M. Tolaney; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Antonio Llombart-Cussac; Hatem Soliman; Hong Wang; Sameera Wijayawardana; Valerie M. Jansen et al.
Source: check_circle
Crossref

Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia

Cancer Medicine
2021-11 | Journal article
Contributors: James Sun; Xiaojun Zhong; Junjie Ma; Weihong Sun; Hyo S. Han; Hatem H. Soliman; Loretta S. Loftus; Ricardo L. B. Costa; Avan J. Armaghani; Aixa E. Soyano‐Muller et al.
Source: check_circle
Crossref

A mixed‐methods study of cyclin‐dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers

Cancer Medicine
2021-07 | Journal article
Contributors: Laura B. Oswald; Brandy Arredondo; Mika Kadono; Dinorah Martinez‐Tyson; Cathy D. Meade; Frank Penedo; Michael H. Antoni; Hatem Soliman; Ricardo L. B. Costa; Heather S. L. Jim
Source: check_circle
Crossref

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

BMC Cancer
2020-12 | Journal article
Contributors: Hatem Soliman; Varsha Shah; Gordan Srkalovic; Reshma Mahtani; Ellis Levine; Blanche Mavromatis; Jayanthi Srinivasiah; Mohamad Kassar; Robert Gabordi; Rubina Qamar et al.
Source: check_circle
Crossref

Peer review (3 reviews for 3 publications/grants)

Review activity for Nature (1)
Review activity for Nature cancer. (1)
Review activity for Nature medicine. (1)